Altimmune, Inc. (NASDAQ:ALT – Free Report) – HC Wainwright lifted their Q2 2024 earnings per share estimates for shares of Altimmune in a research report issued to clients and investors on Tuesday, May 14th. HC Wainwright analyst P. Trucchio now forecasts that the company will post earnings of ($0.28) per share for the quarter, up […]